A population-based five-year follow-up study of cervical human papillomavirus infection

Am J Obstet Gynecol. 2000 Sep;183(3):561-7. doi: 10.1067/mob.2000.106749.

Abstract

Objective: The purpose of this study was to determine the long-term tendency for cervical human papillomavirus infections to persist in the general population.

Study design: From 500 women who participated in a 1991 population-based survey, 90 healthy women with normal results of cytologic examination (women with human papillomavirus deoxyribonucleic acid detected and age-matched control women without human papillomavirus deoxyribonucleic acid detected) were interviewed and examined 5 years later colposcopically, cytologically, and with human papillomavirus serologic testing and human papillomavirus deoxyribonucleic acid testing by polymerase chain reaction with 2 different consensus primer pairs (MY09 and MY11 and GP5(+) and GP6(+)), type-specific polymerase chain reaction, and deoxyribonucleic acid sequencing.

Results: The 5-year human papillomavirus clearance rate was 92%. Only human papillomavirus type 16 infections persisted. Colposcopic impression of grade 2 cervical intraepithelial neoplasia was associated with persistent human papillomavirus 16 infection (P <.03). Human papillomavirus detection was associated with sexual history. Human papillomavirus type was the only determinant of human papillomavirus persistence.

Conclusion: The high clearance rates in a population-based setting with a 5-year follow-up period imply that inclusion of human papillomavirus deoxyribonucleic acid testing in population-based cervical screening programs should target persistent infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • Colposcopy
  • DNA, Viral / analysis
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Papillomaviridae* / genetics
  • Papillomaviridae* / immunology
  • Papillomavirus Infections*
  • Polymerase Chain Reaction
  • Tumor Virus Infections*
  • Uterine Cervical Diseases / virology*
  • Uterine Cervical Dysplasia / pathology
  • Uterine Cervical Dysplasia / virology

Substances

  • Antibodies, Viral
  • DNA, Viral